YEADON; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for YEADON; Michael.The latest application filed is for "pyrimidine compositions, ultra-pure compositions and salts thereof, methods of making the same, and methods of using the same for treating histamine h4 receptor (h4) mediated diseases and conditions".

Company Profile

1.4.16

YEADON; Michael - Kent GB
Yeadon; Michael - Sandwich GB
YEADON; Michael - Canterbury GB
Yeadon, Michael - Sandwich Kent GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrimidine Compositions, Ultra-pure Compositions And Salts Thereof, Methods Of Making The Same, And Methods Of Using The Same For Treating Histamine H4 Receptor (h4) Mediated Diseases And Conditions App 20190135787 - ZHU; Zhijian ; et al.	2019-05-09
Pharmaceutical composition for topical administration Grant 10,034,858 - Liu , et al. July 31, 2	2018-07-31
Pharmaceutical Composition For Topical Administration App 20170273945 - LIU; Wai Leung ; et al.	2017-09-28
Pharmaceutical composition for topical administration Grant 9,693,995 - Liu , et al. July 4, 2	2017-07-04
Pyrimidine Compositions, Ultra Pure Compositions And Salts Thereof, Methods Of Making The Same, And Methods Of Using The Same For Treating Histamine H4 Receptor (h4) Mediated Diseases And Conditions App 20170158671 - ZHU; Zhijian ; et al.	2017-06-08
Pharmaceutical Composition For Topical Administration App 20170007576 - LIU; Wai Leung ; et al.	2017-01-12
Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases App 20070117788 - Yeadon; Michael	2007-05-24
Pharmaceutical combination Grant 7,107,985 - Yeadon September 19, 2	2006-09-19
Pharmaceutical combination App 20060008421 - Yeadon; Michael	2006-01-12
Pharmaceutical combination Grant 6,974,803 - Yeadon December 13, 2	2005-12-13
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases App 20050250730 - Yeadon, Michael ; et al.	2005-11-10
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases App 20050209185 - Yeadon, Michael ; et al.	2005-09-22
Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases App 20050107420 - Armstrong, Roisin A. ; et al.	2005-05-19
Adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases App 20040171576 - Yeadon, Michael ; et al.	2004-09-02
Pharmaceutical combination App 20040167153 - Yeadon, Michael	2004-08-26
Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases App 20040147544 - Yeadon, Michael ; et al.	2004-07-29
Pharmaceutical combination App 20030139369 - Yeadon, Michael	2003-07-24
Pharmaceutical combination App 20030119862 - Yeadon, Michael	2003-06-26
Pharmaceutical combination App 20030109485 - Yeadon, Michael	2003-06-12
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases App 20030013675 - Yeadon, Michael ; et al.	2003-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.